ARCHIVES

Celgene Signs CRADA With NCI For Development Of CDC-501.

This article is from The Cancer Letter archive.

Vol. 26 No. 26 | June 30, 2000

Download PDF Visit The Full Archive

Related Articles

Perifosine, Sorafenib Combination Well Tolerated in Several Lymphomas

December 28, 2012

New Evidence Shows Polyp Removal Lowers Death Rate at 23-Year Follow-up

February 24, 2012

Healy Saw Scripps Issue as Way To Revisit Conflict Of Interest

March 19, 1993

House Passes Cancer Bill With Mandates for NCI

September 28, 2012

Most Older Men With Early Prostate Cancer Can Avoid Treatment, Analysis Finds

February 29, 2008

Waxman Hearing Turns Out Strong Support For Cancer Program Renewal

February 29, 1980